Cargando…
Antithrombotic Therapy in a Prospective Trial of a Pediatric Ventricular Assist Device
Efficacious ventricular assist device (VAD) support in pediatric patients depends on successful antithrombotic management. The experience with antithrombotic management for the EXCOR Pediatric VAD Investigational Device Exemption (IDE) study is described. All 68 children in North America enrolled in...
Autores principales: | Steiner, Marie E., Bomgaars, Lisa R., Massicotte, M. Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098459/ https://www.ncbi.nlm.nih.gov/pubmed/27556152 http://dx.doi.org/10.1097/MAT.0000000000000434 |
Ejemplares similares
-
Left ventricular assist devices and right ventricular failure prediction: Quo Vadis?
por: Lorusso, Roberto, et al.
Publicado: (2021) -
Hemodynamic Performance of a Novel Right Ventricular Assist Device (PERKAT)
por: Kretzschmar, Daniel, et al.
Publicado: (2017) -
Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022) -
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device
por: Silvestry, Scott C., et al.
Publicado: (2020) -
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist Device
por: Mahr, Claudius, et al.
Publicado: (2020)